深圳市海普瑞药业集团股份有限公司（09989）于2026年3月3日发布截至2026年2月28日的股份变动月报表。报告期内，公司股本结构未发生新增发行或回购注销等变化，股本继续保持稳定。
根据公告，公司于香港联交所上市的H股维持220,094,500股；于深圳证券交易所上市的A股则维持1,247,201,704股。截至2026年2月28日，注册股本总额为人民币1,467,296,204元。公司在报告期内无任何期权、认股权证或可换股票据的发行、行使或注销情形。
公告显示，公司确认遵守香港联合交易所有限公司《上市规则》及相关法律法规。上述月报表由联席公司秘书钱风奇签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.